T
Thomas B. Brunner
Researcher at University Medical Center Freiburg
Publications - 21
Citations - 464
Thomas B. Brunner is an academic researcher from University Medical Center Freiburg. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 7, co-authored 21 publications receiving 311 citations.
Papers
More filters
Journal ArticleDOI
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
N. Andratschke,H. Alheid,Michael Allgäuer,Gerhild Becker,Oliver Blanck,Judit Boda-Heggemann,Thomas B. Brunner,Marciana-Nona Duma,Sabine Gerum,Matthias Guckenberger,Guido Hildebrandt,Rainer J. Klement,V. Lewitzki,C. Ostheimer,Alexandros Papachristofilou,Cordula Petersen,Thomas Schneider,Robert Semrau,Stefan Wachter,Daniel Habermehl +19 more
TL;DR: After an initial learning curve with regards to total cumulative doses, consistently high biologically effective doses have been employed translating into high local tumor control at 1 and 2 years and overall survival is mainly influenced by histology and metastatic tumor burden.
Journal ArticleDOI
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
Ursula Nestle,Ursula Nestle,Tanja Schimek-Jasch,Stephanie Kremp,Andrea Schaefer-Schuler,Michael Mix,Andreas Küsters,M. Tosch,Thomas Hehr,Susanne Martina Eschmann,Y. Bultel,Peter Hass,Jochen Fleckenstein,Alexander Thieme,M. Stockinger,Karin Dieckmann,Matthias Miederer,Gabriele Holl,H. Christian Rischke,Eleni Gkika,Sonja Adebahr,Sonja Adebahr,Jochem König,Anca-Ligia Grosu,Anca-Ligia Grosu,Anca L. Grosu,Wolfgang Weber,Philipp T. Meyer,H Hoffmanns,Ursula Nestle,R Aurisch,Wolfgang Schäfer,T Hehr,S M Eschmann,W Dornoff,B Siekmeyer,L Trampert,Günther Gademann,Thomas B. Brunner,A Amthauer,J Ricke,M Pech,Christian Rübe,Carl-Martin Kirsch,S Ezzidin,H. Schmidberger,M Schreckenberger,M Bamberg,Daniel Zips,R Bares,C La Fougere,Volker Budach,W Brenner,M Beck,R Freiherr von Gumppenberg,D Aebersold,Th. Krause,H J Feldmann,A Hertel,G Stüben,J Sciuk,H Annweiler,G Holl,W Oehler,I Schlöcker,R Baum,B Kimmig,J Dunst,E Henze,U Lützen,M Schwaiger,K Strehle,W Alberti,M Piroth,M Tosch,R Pötter,Joachim Widder,C Herold,U Freund,Felix Momm,M L Sautter-Bihl,K Tatsch,Guido Hildebrandt,Bernd J. Krause +83 more
TL;DR: 18F-FDG PET-based planning could potentially improve local control and does not seem to increase toxicity in patients with chemoradiotherapy-treated locally advanced non-small-cell lung cancer.
Journal ArticleDOI
Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO Working Group on Stereotactic Radiotherapy.
Florian Sterzing,Thomas B. Brunner,Iris Ernst,Wolfgang W. Baus,Burkhard Greve,Klaus Herfarth,Matthias Guckenberger +6 more
TL;DR: Recommendations were developed for patient selection, imaging, planning, treatment delivery, motion management, dose reporting, and follow-up and radiation dose constraints to critical organs at risk are provided.
Journal ArticleDOI
Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control.
Rainer J. Klement,M. Guckenberger,H. Alheid,Michael Allgäuer,Gerhild Becker,Oliver Blanck,Judit Boda-Heggemann,Thomas B. Brunner,Marciana Nona Duma,Sabine Gerum,Daniel Habermehl,Guido Hildebrandt,V. Lewitzki,C. Ostheimer,Alexandros Papachristofilou,Cordula Petersen,Thomas Schneider,Robert Semrau,Stefan Wachter,Nicolaus Andratschke +19 more
TL;DR: Besides dose, histology and pretreatment chemotherapy were important factors influencing local TCP in this large cohort of liver metastases, adding to the emerging evidence that breast cancer metastases do respond better to hypofractionated SBRT compared to other histologies.
Journal ArticleDOI
Impact of 4D-(18)FDG-PET/CT imaging on target volume delineation in SBRT patients with central versus peripheral lung tumors. Multi-reader comparative study.
A. Chirindel,Sonja Adebahr,Daniel Schuster,Tanja Schimek-Jasch,Daniel H. Schanne,U. Nemer,Michael Mix,Philipp T. Meyer,Anca-Ligia Grosu,Thomas B. Brunner,Ursula Nestle +10 more
TL;DR: The addition of co-registered 4DPET data to 4DCT based target volume delineation for SBRT of centrally located lung tumors increases the inter-observer agreement and may help to avoid geographic misses.